Complex pharmacology of natural cannabivoids: Evidence for partial agonist activity of Δ9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors
- 29 May 1998
- journal article
- research article
- Published by Elsevier BV in Life Sciences
- Vol. 63 (1), PL1-PL6
- https://doi.org/10.1016/s0024-3205(98)00238-0
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Interaction of brain cannabinoid receptors with guanine nucleotide binding protein: A radioligand binding studyBiochemical Pharmacology, 1997
- Δ9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brainEuropean Journal of Pharmacology, 1997
- Cannabinoid receptor stimulation of guanosine-5′-O-(3-[35S]thio)triphosphate binding in rat brain membranesLife Sciences, 1996
- (—)-Δ9-Tetrahydrocannabinol Antagonizes the Peripheral Cannabinoid Receptor-mediated Inhibition of Adenylyl CyclasePublished by Elsevier BV ,1996
- The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein couplingFEBS Letters, 1995
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorFEBS Letters, 1994
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Cannabinoid receptor agonists inhibit Ca current in NG108–15 neuroblastoma cells via a Pertussis toxin‐sensitive mechanismBritish Journal of Pharmacology, 1992
- Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in manEuropean Journal of Pharmacology, 1974
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964